Article Details
Retrieved on: 2025-03-04 12:36:18
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the biotechnology company Cybrexa Therapeutics and their alphalex™ peptide-drug conjugates, which selectively deliver potent anticancer agents to tumors, offering a novel alternative to antibody-drug conjugates. This connects to tags like antineoplastic drugs and antibody-drug conjugate but not directly to others like hepatocyte growth factor receptor.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here